2016 Press Releases
<td “width=’20%”‘>Date
<td “width=’60%”‘>Headline <td “width=’20%”‘>View
2015 Press Releases
<td “width=’20%”‘>Date
<td “width=’60%”‘>Headline <td “width=’20%”‘>View
| December 3, 2015 |
First Patient Enrolled in Toca 5, Tocagen’s Phase 2/3 Clinical Trial |
 |
| November 23, 2015 |
Tocagen Presents Updated Data at the SNO and SNO-SCIDOT Conferences |
|
| November 18, 2015 |
Tocagen Announces Presentations at the SNO and SNO-SCIDOT Conferences |
|
| September 10, 2015 |
Lori Kunkel, M.D., Joins Tocagen’s Board of Directors |
|
| September 3, 2015 |
Tocagen to Present at BioCentury’s NewsMakers in the Biotech Industry Conference |
|
| August 25, 2015 |
FDA Grants Orphan Designation for Toca 511 & Toca FC |
|
| July 9, 2015 |
FDA Grants Fast Track Designation to Tocagen’s Toca 511 & Toca FC for Treatment of Recurrent High Grade Glioma |
|
| June 17, 2015 |
Tocagen Appoints Asha Das, M.D, as Vice President Clinical Development and Medical Affairs |
|
| May 5, 2015 |
Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors |
|
| May 4, 2015 |
Tocagen Announces Updates from FDA Meeting and Clinical Data Presentations at AANS/CNS |
|
| April 30, 2015 |
Tocagen Announces Presentations at the AANS/CNS Joint Section on Tumors |
|
| February 25, 2015 |
Tocagen Appoints Paul Schimmel, Ph.D, to the Board of Directors |
|
Press Release Archives
